tiprankstipranks
Roche’s mixed myasthenia gravis data sending these stocks in opposite directions
PremiumThe FlyRoche’s mixed myasthenia gravis data sending these stocks in opposite directions
2M ago
Roche’s mixed myasthenia gravis data sending these stocks in opposite directions
PremiumThe Fly
Roche’s mixed myasthenia gravis data sending these stocks in opposite directions
2M ago
Tourmaline Bio might see weakness today after Roche MG data, says Truist
PremiumThe Fly
Tourmaline Bio might see weakness today after Roche MG data, says Truist
2M ago
Immunovant initiated with an Overweight at JPMorgan
PremiumThe FlyImmunovant initiated with an Overweight at JPMorgan
3M ago
Wolfe starts Immunovant at Outperform, says excited about catalyst path
PremiumThe Fly
Wolfe starts Immunovant at Outperform, says excited about catalyst path
3M ago
Immunovant initiated with an Outperform at Wolfe Research
PremiumThe Fly
Immunovant initiated with an Outperform at Wolfe Research
3M ago
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023
PremiumPress ReleasesImmunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023
3M ago
Immunovant reports Q3 EPS (36c), consensus (43c)
PremiumThe Fly
Immunovant reports Q3 EPS (36c), consensus (43c)
3M ago
The biotech stocks to own in 2024, according to Piper Sandler
PremiumThe Fly
The biotech stocks to own in 2024, according to Piper Sandler
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100